Cost Comparison of Finasteride and Dutasteride for Enlarged Prostate in a Managed Care Setting Among Medicare-aged MenByMichael Naslund, MD, MBA,Michael T. Eaddy, PharmD, PhD,Eric J. Kruep, PharmD, MS,Susan L. Hogue, PharmD, MPHMay 1st 2008
Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged MenByMuta M. Issa, MD, MBA,Pei-Jung Lin, PhD,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,E. Anne Davis, PharmD, MSMay 1st 2008
Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 YearsByThomas C. Fenter, MD,E. Anne Davis, PharmD, MS,Manan B. Shah, PharmD, PhD,Pei-Jung Lin, PhDMay 1st 2008
5-Alpha Reductase Inhibitors in Men With an Enlarged Prostate: An Evaluation of Outcomes and Therapeutic AlternativesByMichael Naslund, MD, MBA,Timothy S. Regan, BPharm, RPh, CPh,Christine Ong, PharmD, MBA, BS,Susan L. Hogue, PharmD, MPHMay 1st 2008
